Cancer Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Cancer Gene Therapy
Research from T. Kidner and co-researchers yields new findings on cancer gene therapy
June 17th, 2008
According to recent research from the United States, "Hepatocellular cancer (HCC) is the fifth-leading cause of cancer and the third-leading cause of cancer related deaths world-wide." "Current treatment options are limited, as HCC has been shown to be a highly resistant type of cancer to most current treatment modalities. Novel approaches are being explored in the fields of gene therapy, viral oncolytics, radioembolization, and several new biologic therapies," wrote T. Kidner and colleagues. The researchers concluded: "This article summarizes these recent clinical findings and discusses what role they will have in the future treatment of...
Source: Cancer Weekly (2008-06-17)
|
